Stay Informed on Key Developments

Investor News and Updates

Bill_Ipad

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

111 - 120of 392 News
111 - 120of 392 News
March 28, 2022
Not intended for U.S. and UK Media
Bayer receives approval in Japan for Kerendia™ (finerenone), a new treatment for adults with chronic kidney disease and type 2 diabetes
READ MORE
March 22, 2022
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN
Bayer refinances 1.3 billion euro hybrid bond
READ MORE
March 11, 2022
Not intended for U.S. and UK Media
Bayer submits application for additional indication of Nubeqa™ (darolutamide) in Japan
READ MORE
March 10, 2022
Bayer to sell its Environmental Science Professional business to Cinven for 2.6 billion U.S. dollars
READ MORE
March 09, 2022
Not intended for U.S. and UK Media
Bayer submits applications in the U.S. and EU for additional indication of Nubeqa™ (darolutamide)
READ MORE
March 01, 2022
Fiscal 2021:
Bayer: Dynamic growth - progress in innovation
READ MORE
February 24, 2022
Not intended for U.S. and UK Media
Bayer extends clinical development program for finerenone with Phase II study investigating the l combination therapy with empagliflozin in patients with chronic kidney disease and type 2 diabetes
READ MORE
February 21, 2022
Not intended for U.S. and UK Media
Bayer’s new treatment Kerendia® (finerenone) approved in EU for adult patients with chronic kidney disease associated with type 2 diabetes
READ MORE
February 17, 2022
Not intended for U.S. and UK Media
Bayer raises peak sales for Nubeqa to exceed three billion euro amid positive Phase III ARASENS trial data
READ MORE
February 17, 2022
Not intended for U.S. and UK Media - Data from Phase III ARASENS trial presented at 2022 ASCO GU Cancers Symposium:
Darolutamide plus androgen deprivation therapy and docetaxel significantly increases overall survival in patients with metastatic hormone-sensitive prostate cancer
READ MORE
111 - 120of 392 News
111 - 120of 392 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more